- Joined
- Oct 13, 2008
- Messages
- 7,301
- Reaction score
- 5,518
"The Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,” which extends exceptions to existing DEA regulations related to establishing new practitioner-patient relationships through December 31, 2024.
This extension authorizes all DEA-registered practitioners to prescribe schedule II-V controlled medications via telemedicine through December 31, 2024... The DEA announced it expects to release a final rule by the Fall of 2024."
This extension authorizes all DEA-registered practitioners to prescribe schedule II-V controlled medications via telemedicine through December 31, 2024... The DEA announced it expects to release a final rule by the Fall of 2024."